ArticleAesthetic surgery journal. Open forum2025
AlloDerm Vs DermACELL in Breast Reconstruction: A Systematic Review and Meta-Analysis of All Head-to-Head Comparisons.
Article in Aesthetic surgery journal. Open forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Analysis of Essence Human Acellular Dermal Matrix Compared With Other Products in Prepectoral Direct-to-implant Reconstruction.Plastic and reconstructive surgery. Global open · 2026Article
- AlloDerm Versus Cortiva: A Multicenter Pooled Analysis of Clinical and Economic Outcomes in Breast Reconstruction.Plastic and reconstructive surgery. Global open · 2026Article
- Prepectoral direct-to-implant breast reconstruction using a novel acellular dermal matrix: framework for a cohort study.International journal of surgery protocols · 2025Article
- Bleeding, Drains, and Reoperation in Transmasculine Chest Surgery: What 2,534 Patients Tell Us About Tranexamic Acid.Plastic and reconstructive surgery. Global open · 2025Article
- AlloDerm® versus Cortiva® in implant-based breast reconstruction: framework for a systematic review and meta-analysis of clinical and economic outcomes.Systematic reviews · 2025Article
- Primary Nipple-Repositioning Surgery Before Nipple-sparing Mastectomy in Large or Ptotic Breasts: A Multicenter Cohort Analysis.Plastic and reconstructive surgery. Global open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: AlloDerm (LifeCell, Branchburg, NJ) and DermACELL (LifeNet Health, Virginia Beach, VA) are 2 commonly used acellular dermal matrices (ADMs) in aesthetic and reconstructive breast surgery. Objectives: In this head-to-head meta-analysis, the authors aim to compare the clinical outcomes, including complication rates and BREAST-Q patient satisfaction, associated with AlloDerm and DermACELL. Methods: PubMed, Scopus, and Web of Science were searched for relevant studies in April 2024 and again in April 2025. The authors included all studies with data comparing AlloDerm and DermACELL. Statistical analyses were performed using RevMan 5.4. Heterogeneity was assessed using Results: The search yielded 1006 studies, of which 14 were included in the meta-analysis. A total of 1872 patients (2940 breasts) were analyzed, with 1724 breasts receiving AlloDerm and 1433 breasts receiving DermACELL. The analysis revealed that AlloDerm was associated with a slightly higher incidence of seroma formation (risk ratio = 1.49, 95% CI, 1.14-1.95, Conclusions: DermACELL demonstrated a slightly lower incidence of seroma formation compared with AlloDerm. Further randomized trials are needed to confirm these results and explore the long-term outcomes associated with both ADMs. Level of Evidence 3 Therapeutic:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.